tiprankstipranks
Trending News
More News >
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
:0719

Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Revenue

Compare
2 Followers

Shandong Xinhua Pharmaceutical Company Limited Class H Revenue

Shandong Xinhua Pharmaceutical Company Limited Class H had a revenue of 2.12B in the quarter ending Sep 30, 2025, with -3.89%. This bring the company's revenue in the last twelve months to 8.49B, Decreased 1.45%. In the fiscal year ending Dec 31, 2024, Shandong Xinhua Pharmaceutical Company Limited Class H had annual revenue of 8.47B with 4.51% growth.
Revenue (ttm)
8.49B
Revenue Growth
1.65%
P/S Ratio
1.15
Revenue/Employee
HK$1,160,404
Employees
7,296
Market Cap
HK$9.72B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
8.47B365.47M+4.51%
Dec 31, 2023
8.10B597.86M+7.97%
Dec 31, 2022
7.50B942.91M+14.37%
Dec 31, 2021
6.56B554.49M+9.23%
Dec 31, 2020
6.01B399.57M+7.13%
Dec 31, 2019
5.61B398.15M+7.65%
Dec 31, 2018
5.21B692.15M+15.33%
Dec 31, 2017
4.52B